Scientific program
| Symposia
Home > Scientific program
Symposium I: Calcium Metabolism and Atherosclerosis | Friday, September 12th (09:00–10:30) - Convention Hall A Chairpersons : Hyun Ho Shin, Inkyu Lee |
Hyun-Jai Cho Seoul National University, Korea |
S1-1 Molecular Regulator of Vascular Calcification in Atherosclerosis |
|
Sung Hee Choi Seoul National University, Korea |
S1-2 Clinical: Vascular Calcification Imaging |
|
Ian Reid University of Auckland, New Zealand |
S1-3 TBD |
|
Symposium Ⅱ: Treatment of Subclinical Atherosclerosis | Friday, September 12th (13:20-15:20) - Convention Hall B Chairpersons : Hong Kyu Lee, Young-Bae Park |
Ki Hoon Han University of Ulsan, Korea |
S2-1 Statin for Primary Prevention in Subclinical Atherosclerosis |
|
Jinkwon Kim Cha University, Korea |
S2-2 Antiplatelet Agent for Primary Prevention in Subclinical Atherosclerosis |
|
Yun-Hyeong Cho Myongji Hospital, Korea |
S2-3 Nonmedical Intervention for Subclinical Atherosclerosis |
Symposium Ⅲ: Evidence-based Cardiovascular Disease Prediction and Prevention | Friday, September 12th (15:40~17:40) - Convention Hall A Chairpersons : Ho Young Son, Sung Chull Chae |
Nathan D. Wong University of California in Irvine, USA |
S3-1 CVD Risk Stratification, Management of Dyslipidemia for Primary and Secondary Prevention USA |
|
Chang Hee Jung University of Ulsan, Korea |
S3-2 CVD Risk Stratification, Management of Dyslipidemia for Primary and Secondary Prevention Korea |
|
Ken-ichi Hirata Kobe University, Japan |
S3-3 CVD Risk Stratification, Management of Dyslipidemia for Primary and Secondary Prevention Japan |
|
TBD | S3-4 CVD Risk Stratification, Management of Dyslipidemia for Primary and Secondary Prevention China |
Symposium Ⅳ: Nutrition and Inflammation |
Friday, September 12th (15:40~17:40) - Convention Hall B Chairpersons : Hyun-Sook Kim, Yangha Kim |
Jong Ho Lee Yonsei University, Korea |
S4-1 Verification of Metabolic Disease Related-new Nutritional Metabolites Based on Clinical Nutrigenetic and Metabolomic Technology |
|
Won Ho Kim Korea Centers for Disease Control and Prevention, Korea |
S4-2 The Role of Activation Transcription Factor 3 (ATF3) on the Progression of Type 2 Diabetes and Its Complication |
|
Gary Sweeney York University, Canada |
S4-3 Recent Insights on Mechanisms of Cardiovascular Complications in Type 2 Diabetes |
Symposium Ⅴ: Immune Cells and Autophagy in Metabolic Disease | Saturday, September 13th (08:40-10:40) - Convention Hall A Chairpersons : Hun Taeg Chung, Youngmi Kim |
Young Mi Park Ewha Womans University, Korea |
S5-1 Macrophage in the Pathogenesis of Atherosclerosis |
|
Cheolho Cheong University of Montreal, Canada |
S5-2 The Role of Subsets of Vascular Dendritic Cell in Atherosclerosis |
|
Clinton Robbins University of Toronto, Canada |
S5-3 The Development of Myeloid Responses in Vascular Health and Disease |
|
Goo Yaeg Oh Ewha Womans University, Korea |
S5-4 ROS Induced Autophagy in the Pathogenesis of Atherosclerosis |
|
Myung-Shik Lee Sungkyunkwan University, Korea |
S5-5 Autophagy in the Metabolic Disease |
|
Panels : Chi Dae Kim, Sang-Hak Lee, Hae-Young Lee, Jin Han |
Symposium Ⅵ: Promising Anti-atherosclerotic Approaches on Coronary Disease | Saturday, September 13th (14:00-15:30) - Convention Hall A Chairpersons : Sang Hong Baek, Kyong Soo Park |
Sang Hyun Kim Seoul National University, Korea |
S6-1 Lipid Modulations Except Statin and Atherosclerosis |
|
Hae-Young Lee Seoul National University, Korea |
S6-2 New Evolving Anti-inflammatory Agents on Atherosclerosis |
|
Cheol Whan Lee University of Ulsan, Korea |
S6-3 Antiplatelet Drugs for Prevention of Atherothrombotic Event-Do We Need New Options? |
Symposium Ⅶ: Diabetes and Atherosclerosis |
Saturday, September 13th (15:50-17:30) - Convention Hall A Chairpersons : Hong-Seog Seo, Joong-Yeol Park |
Kwanpyo Koh Jeju National University, Korea |
S7-1 Conventional Oral Antidiabetic Agents and Cardiovascular Disease |
|
Eun-Jung Rhee Sungkyunkwan University, Korea |
S7-2 Thiazolidinedione and Cardiovascular Disease |
|
Soo Lim Seoul National University, Korea |
S7-3 Incretin-based Therapy and Cardiovascular Disease |
Organizations-KSLA Joint Symposium: Future of Clinical Trial and Research in Korea | Saturday, September 13th (14:00-15:30) - Convention Hall B Chairperson : Donghoon Choi |
Dong-Ho Shin Yonsei University, Korea |
JS-1 How to Deal with Obstacles of Clinical Research |
|
MIN SOO PARK Yonsei University, Korea |
JS-2 What Researchers Need to Know about Conflict of Interest |
|
Ki Hwan Choi Ministry of Food and Drug Safety, Korea |
JS-3 Clinical Trial for New Drug Approval in Korea |
|
Panels : Jaetaek Kim, Jin Kim, Kichang Nam, Young-Jack Lee |
Presentation for Projects Funded by KSLA(Korean) |
Saturday, September 13th (15:50-17:30) - Convention Hall B Chairpersons : Hak Chul Jang, Jin Han |
Woo Je Lee University of Ulsan, Korea |
P-1 The Validation of Usefulness of Serum Apolipoprotein B/apolipoprotein A1 Ratio in Detecting the Subjects with Metabolic Syndrome in a Korean Population |
|
Jee Hyun An Korea University, Korea |
P-2 Effects of Thyroid Hormone Withdrawal on Metabolic and Cardiovascular Parameters During Radioactive Iodine Therapy in Differentiated Thyroid Cancer |
|
Woo-Young Chung Seoul National University, Korea |
P-3 The Serum Concentration of MicroRNA-33 and Its Changes by Statin Treatment in High LDL Cholesterolemic Patients |
|
Jae-Hoon Choi Hanyang University, Korea |
P-3 Identification of Whole Immune Cell Population in Normal and Atherosclerotic Mouse Aorta |
Basic Research Committee Workshop: New Hope for Vascular Biology(Korean) | Friday, September 12th (09:00-10:30) - Convention Hall B Chairpersons : Jeong Euy Park, Chi Dae Kim |
Injune Kim Korea Advanced Institute of Science and Technology, Korea |
BRCW-1 The Role of Sox17 in the Vascular Health and Disease |
|
Chung-Hyun Cho Seoul National University, Korea |
BRCW-2 Angiopoietin 2 Mediates High Glucose-induced Pericyte Apoptosis in a Integrin Dependent Manner |
|
Kyu-Tae Kang Duksung Women’s University, Korea |
BRCW-3 Building Blood Vessels Using Human Vasculogenic Cells: Clinical Application |
|
Panels : Nari Kim, Jae Ryong Kim, Jae-Hoon Choi |
Oral Presentation 1, 2 |
Friday, September 12th (13:20-15:20) - Convention Hall A Chairpersons : Moon Suk Nam, Youngkeun Ahn |
TBD | OP-1 Oral Presentation 1 |
|
TBD | OP-2 Oral Presentation 1 |
|
TBD | OP-3 Oral Presentation 2 |
|
TBD | OP-4 Oral Presentation 2 |